Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 18376 | 489 | 27.3 | 42% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | CELIPROLOL | Author keyword | 17 | 36% | 8% | 39 |
| 2 | BEVANTOLOL | Author keyword | 3 | 40% | 1% | 6 |
| 3 | PERINDOPRIL THERAPEUTIC USE | Author keyword | 1 | 100% | 0% | 2 |
| 4 | VERAPAMIL THERAPEUTIC USE | Author keyword | 1 | 50% | 0% | 2 |
| 5 | PERIPHERAL VASCULAR DISEASES DRUG THERAPY | Author keyword | 1 | 33% | 1% | 3 |
| 6 | CARDIOSELECTIVITY | Author keyword | 1 | 27% | 1% | 3 |
| 7 | INTERMITTENT CLAUDICATION DRUG THERAPY | Author keyword | 1 | 25% | 1% | 3 |
| 8 | AORTIC MASS | Author keyword | 1 | 50% | 0% | 1 |
| 9 | ATENOLOL THERAPEUTIC USE | Author keyword | 1 | 50% | 0% | 1 |
| 10 | BEVANTOLOL HYDROCHLORIDE | Author keyword | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | NONCARDIOSELECTIVE BETA BLOCKERS | 3 | 100% | 1% | 3 |
| 2 | MILDLY HYPERTENSIVE PATIENTS | 3 | 60% | 1% | 3 |
| 3 | BETA 1 ADRENOCEPTOR ANTAGONIST | 1 | 50% | 0% | 2 |
| 4 | CARDIOSELECTIVE BETA BLOCKER | 1 | 50% | 0% | 2 |
| 5 | CELIPROLOL | 1 | 15% | 2% | 8 |
| 6 | INTRINSIC SYMPATHOMIMETIC ACTIVITY | 1 | 10% | 2% | 8 |
| 7 | BETA 2 ADRENOCEPTOR ANTAGONISM | 1 | 50% | 0% | 1 |
| 8 | LOCAL COLD | 1 | 50% | 0% | 1 |
| 9 | R CELIPROLOL | 1 | 50% | 0% | 1 |
| 10 | CALF BLOOD FLOW | 1 | 29% | 0% | 2 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| CELIPROLOL - AN UPDATED REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC EFFICACY IN CARDIOVASCULAR-DISEASE | 1991 | 57 | 71 | 79% |
| Beta blockers for peripheral arterial disease | 2013 | 2 | 41 | 46% |
| CELIPROLOL - AN EVALUATION OF ITS PHARMACOLOGICAL PROPERTIES AND CLINICAL EFFICACY IN THE MANAGEMENT OF HYPERTENSION AND ANGINA-PECTORIS | 1995 | 16 | 72 | 74% |
| Beta blockers for peripheral arterial disease | 2008 | 10 | 27 | 59% |
| Treatment of hypertension in peripheral arterial disease | 2009 | 8 | 76 | 32% |
| CELIPROLOL - A PRELIMINARY REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES AND ITS THERAPEUTIC USE IN HYPERTENSION AND ANGINA-PECTORIS | 1987 | 45 | 50 | 82% |
| beta-adrenergic blocking agents and intermittent claudication: Systematic review | 2004 | 5 | 15 | 40% |
| Treatment of hypertension in peripheral arterial disease | 2013 | 1 | 94 | 29% |
| Vasodilating beta-adrenoceptor blockers as cardiovascular therapeutics | 2003 | 49 | 265 | 15% |
| BEVANTOLOL - A PRELIMINARY REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC EFFICACY IN HYPERTENSION AND ANGINA-PECTORIS | 1988 | 10 | 27 | 67% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | ABT INTERVENT KARDIOL | 0 | 33% | 0.2% | 1 |
| 2 | TONI HOSP | 0 | 33% | 0.2% | 1 |
| 3 | CHAIR ANGIOL | 0 | 25% | 0.2% | 1 |
| 4 | PHARMACEUT MED COMMUN | 0 | 17% | 0.2% | 1 |
| 5 | N CHICAGO VA MED | 0 | 13% | 0.2% | 1 |
| 6 | CATEDRA QUIM ORGAN 1 CATEDRA QUIM ANALIT | 0 | 100% | 0.2% | 1 |
| 7 | ST MARYS HOSP RENAL MEDRENAL UNIT | 0 | 100% | 0.2% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000270875 | RECEPTOR OCCUPANCY THEORY//DIACETOLOL//TERNARY COMPLEX MODEL |
| 2 | 0.0000244397 | BISOPROLOL//CARDIOSELECTIVE BETA BLOCKERS//CARDIOSELECTIVE |
| 3 | 0.0000221703 | AMOSULALOL//TERTATOLOL//DILEVALOL |
| 4 | 0.0000220236 | ANTIHYPERTENSIVE PHARMACOTHERAPY//BETA1 BLOCKADE//CARDIOVASC P REHABIL UNIT |
| 5 | 0.0000203632 | BOPINDOLOL//NIPRADILOL//H 3 CGP12177 |
| 6 | 0.0000108074 | XAMOTEROL//EPANOLOL//DENOPAMINE |
| 7 | 0.0000103016 | DOXAZOSIN//AJ 2615//MONATEPIL MALEATE |
| 8 | 0.0000095131 | T 0509//ZINTEROL//BETA ADRENERGIC RECEPTOR SUBTYPE |
| 9 | 0.0000093409 | ABT MED FOR//CARDIOSELECTIVE BETA RECEPTOR ANTAGONIST//PAREXEL GMBH |
| 10 | 0.0000093098 | COLLATERAL CORONARY FLOW//ADV MED TRAINING STATE//BETA BLOCKER |